AGO2 and cancer: Two main populations of circulating miRNAs identified from plasma are as follows: (i) non-vesicle-associated plasma miRNAs with the Ago2 ribonucleoprotein complex; and (ii) a minority of specific miRNAs associated predominantly with vesicles such as exosomes enable their utilization as blood-based biomarkers for cancer and many diseases alike [64].